Cancer is one of the leading causes of death and places a significant and growing burden on healthcare systems around the world1.

Sandoz is committed to increasing physician and patient access to broader options for quality cancer treatments that make up the foundation of cancer care. Biosimilar treatment options could free up resources, which can be redeployed for innovation, access and new interventions within healthcare systems to support and manage the burden of oncology care.

Beyond providing high-quality affordable medicines, Sandoz is also committed to improve health care infrastructures worldwide through various partnerships and dedicated teams in many countries interacting daily with health care practitioners, providers, payers and patients.

  1. World Health Organization. World Cancer Report 2014. Available at: [Accessed January 2019]